Progyny, Inc. Increase (Decrease) in Accounts Payable
Progyny, Inc. (PGNY) reported Increase (Decrease) in Accounts Payable of $27.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-07
- Progyny, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$5.79M.
- Progyny, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $33.63M, a 32.21% decline year-over-year.
- Progyny, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $1.09M.
- Progyny, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$17.55M.
- Progyny, Inc. increase (decrease) in accounts payable for fiscal 2025 was $28.75M.
- Progyny, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$30.27M, a 286.44% decline from fiscal 2023.
- Progyny, Inc. increase (decrease) in accounts payable for fiscal 2023 was $16.23M, a 65.96% decline from fiscal 2022.
- Progyny, Inc. increase (decrease) in accounts payable for fiscal 2022 was $47.69M, a 167.32% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $27.84M 10-Q · filed 2026-08-07 | $28.93M derived: sum of 3 quarters · filed 2026-08-07 | $11.39M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $33.63M 10-Q · filed 2026-05-08 | $34.73M derived: sum of 2 quarters · filed 2026-05-08 | $17.18M derived: sum of 3 quarters · filed 2026-05-08 | $12.77M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$16.45M derived: sum of 2 quarters · filed 2026-02-27 | -$20.87M derived: sum of 3 quarters · filed 2026-08-07 | $28.75M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$17.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$21.96M derived: sum of 2 quarters · filed 2026-08-07 | $27.66M 10-Q · filed 2025-11-07 | -$7.68M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$4.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $45.21M 10-Q · filed 2026-08-07 | $9.87M derived: sum of 3 quarters · filed 2026-08-07 | -$11.46M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $49.62M 10-Q · filed 2026-05-08 | $14.28M derived: sum of 2 quarters · filed 2026-05-08 | -$7.05M derived: sum of 3 quarters · filed 2026-05-08 | $14.56M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$35.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$56.66M derived: sum of 2 quarters · filed 2026-02-27 | -$35.06M derived: sum of 3 quarters · filed 2026-02-27 | -$30.27M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$21.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $282.00K derived: sum of 2 quarters · filed 2025-11-07 | $5.07M 10-Q · filed 2025-11-07 | -$1.58M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $21.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $26.40M 10-Q · filed 2025-08-08 | $19.75M derived: sum of 3 quarters · filed 2026-02-27 | $21.78M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $4.79M 10-Q · filed 2025-05-09 | -$1.86M derived: sum of 2 quarters · filed 2026-02-27 | $172.00K derived: sum of 3 quarters · filed 2026-02-27 | -$15.42M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$6.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$4.62M derived: sum of 2 quarters · filed 2026-02-27 | -$20.21M derived: sum of 3 quarters · filed 2026-02-27 | $16.23M 10-K · filed 2026-02-27 |
| 2023-09-30 | $2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$13.56M derived: sum of 2 quarters · filed 2024-11-12 | $22.88M 10-Q · filed 2024-11-12 | $27.87M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$15.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $20.85M 10-Q · filed 2024-08-07 | $25.84M derived: sum of 3 quarters · filed 2025-03-03 | $37.47M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $36.45M 10-Q · filed 2024-05-10 | $41.43M derived: sum of 2 quarters · filed 2025-03-03 | $53.06M derived: sum of 3 quarters · filed 2025-03-03 | $60.96M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $16.61M derived: sum of 2 quarters · filed 2025-03-03 | $24.52M derived: sum of 3 quarters · filed 2025-03-03 | $47.69M 10-K · filed 2025-03-03 |
| 2022-09-30 | $11.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $19.54M derived: sum of 2 quarters · filed 2023-11-08 | $42.71M 10-Q · filed 2023-11-08 | $48.87M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $7.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $31.07M 10-Q · filed 2023-08-04 | $37.24M derived: sum of 3 quarters · filed 2024-02-29 | $37.82M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $23.17M 10-Q · filed 2023-05-09 | $29.34M derived: sum of 2 quarters · filed 2024-02-29 | $29.92M derived: sum of 3 quarters · filed 2024-02-29 | $27.21M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $6.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $6.75M derived: sum of 2 quarters · filed 2024-02-29 | $4.04M derived: sum of 3 quarters · filed 2024-02-29 | $17.84M 10-K · filed 2024-02-29 |
| 2021-09-30 | $583.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$2.12M derived: sum of 2 quarters · filed 2022-11-04 | $11.67M 10-Q · filed 2022-11-04 | $12.96M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$2.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $11.09M 10-Q · filed 2022-08-05 | $12.38M derived: sum of 3 quarters · filed 2023-03-01 | $23.27M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $13.80M 10-Q · filed 2022-05-06 | $15.09M derived: sum of 2 quarters · filed 2023-03-01 | $25.97M derived: sum of 3 quarters · filed 2023-03-01 | $18.45M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $12.18M derived: sum of 2 quarters · filed 2023-03-01 | $4.65M derived: sum of 3 quarters · filed 2023-03-01 | $25.01M 10-K · filed 2023-03-01 |
| 2020-09-30 | $10.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $3.36M derived: sum of 2 quarters · filed 2021-11-08 | $23.72M 10-Q · filed 2021-11-08 | $20.40M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$7.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $12.83M 10-Q · filed 2021-08-06 | $9.51M derived: sum of 3 quarters · filed 2022-03-01 | $8.79M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $20.36M 10-Q · filed 2021-05-07 | $17.04M derived: sum of 2 quarters · filed 2022-03-01 | $16.32M derived: sum of 3 quarters · filed 2022-03-01 | $20.48M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$4.04M derived: sum of 2 quarters · filed 2022-03-01 | $123.00K derived: sum of 3 quarters · filed 2022-03-01 | $3.50M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$720.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.45M derived: sum of 2 quarters · filed 2020-11-06 | $6.82M 10-Q · filed 2020-11-06 | $9.38M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $4.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $7.54M 10-Q · filed 2020-08-07 | $10.10M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | $3.38M 10-Q · filed 2020-05-14 | $5.93M derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $10.45M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $7.89M 10-Q · filed 2019-12-06 | |||
| 2017-12-31 | -$909.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |